Page last updated: 2024-10-29

iohexol and Carcinoma, Thymic

iohexol has been researched along with Carcinoma, Thymic in 2 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Priola, AM1
Priola, SM1
Gned, D1
Giraudo, MT1
Fornari, A1
Veltri, A1
Qu, YJ1
Liu, GB1
Shi, HS1
Liao, MY1
Yang, GF1
Tian, ZX1

Other Studies

2 other studies available for iohexol and Carcinoma, Thymic

ArticleYear
Comparison of CT and chemical-shift MRI for differentiating thymoma from non-thymomatous conditions in myasthenia gravis: value of qualitative and quantitative assessment.
    Clinical radiology, 2016, Volume: 71, Issue:3

    Topics: Adolescent; Adult; Aged; Contrast Media; Diagnosis, Differential; Humans; Iohexol; Magnetic Resonanc

2016
Preoperative CT findings of thymoma are correlated with postoperative Masaoka clinical stage.
    Academic radiology, 2013, Volume: 20, Issue:1

    Topics: Contrast Media; Female; Humans; Iohexol; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging;

2013